Literature DB >> 32213596

Krüppel-like factor 3 (KLF3) suppresses NF-κB-driven inflammation in mice.

Alexander J Knights1, Lu Yang1, Manan Shah1, Laura J Norton1, Gamran S Green1, Elizabeth S Stout1, Emily J Vohralik1, Merlin Crossley1, Kate G R Quinlan2.   

Abstract

Bacterial products such as lipopolysaccharides (or endotoxin) cause systemic inflammation, resulting in a substantial global health burden. The onset, progression, and resolution of the inflammatory response to endotoxin are usually tightly controlled to avoid chronic inflammation. Members of the NF-κB family of transcription factors are key drivers of inflammation that activate sets of genes in response to inflammatory signals. Such responses are typically short-lived and can be suppressed by proteins that act post-translationally, such as the SOCS (suppressor of cytokine signaling) family. Less is known about direct transcriptional regulation of these responses, however. Here, using a combination of in vitro approaches and in vivo animal models, we show that endotoxin treatment induced expression of the well-characterized transcriptional repressor Krüppel-like factor 3 (KLF3), which, in turn, directly repressed the expression of the NF-κB family member RELA/p65. We also observed that KLF3-deficient mice were hypersensitive to endotoxin and exhibited elevated levels of circulating Ly6C+ monocytes and macrophage-derived inflammatory cytokines. These findings reveal that KLF3 is a fundamental suppressor that operates as a feedback inhibitor of RELA/p65 and may be important in facilitating the resolution of inflammation.
© 2020 Knights et al.

Entities:  

Keywords:  Krüppel-like factor 3 (KLF3); NF-kB transcription factor; NF-kappa B (NF-KB); endotoxin; gene regulation; inflammation; lipopolysaccharide (LPS); macrophage; transcription

Mesh:

Substances:

Year:  2020        PMID: 32213596      PMCID: PMC7196664          DOI: 10.1074/jbc.RA120.013114

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis.

Authors:  Ivan V Kulakovskiy; Ilya E Vorontsov; Ivan S Yevshin; Ruslan N Sharipov; Alla D Fedorova; Eugene I Rumynskiy; Yulia A Medvedeva; Arturo Magana-Mora; Vladimir B Bajic; Dmitry A Papatsenko; Fedor A Kolpakov; Vsevolod J Makeev
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

2.  The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.

Authors:  Alexandre A Steiner; Alla Y Molchanova; M Devrim Dogan; Shreya Patel; Erika Pétervári; Márta Balaskó; Samuel P Wanner; Justin Eales; Daniela L Oliveira; Narender R Gavva; M Camila Almeida; Miklós Székely; Andrej A Romanovsky
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

Review 3.  Rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Iain B McInnes
Journal:  Lancet       Date:  2016-05-03       Impact factor: 79.321

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

5.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

6.  Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes.

Authors:  Hiranmoy Das; Ajay Kumar; Zhiyong Lin; Willmar D Patino; Paul M Hwang; Mark W Feinberg; Pradip K Majumder; Mukesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

7.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.

Authors:  T Fujita; G P Nolan; H C Liou; M L Scott; D Baltimore
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

8.  Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins.

Authors:  N Mori; D Prager
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  Targeted disruption of the basic Krüppel-like factor gene (Klf3) reveals a role in adipogenesis.

Authors:  Nancy Sue; Briony H A Jack; Sally A Eaton; Richard C M Pearson; Alister P W Funnell; Jeremy Turner; Robert Czolij; Gareth Denyer; Shisan Bao; Juan Carlos Molero-Navajas; Andrew Perkins; Yuko Fujiwara; Stuart H Orkin; Kim Bell-Anderson; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

Review 10.  Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential.

Authors:  David R Sweet; Liyan Fan; Paishiun N Hsieh; Mukesh K Jain
Journal:  Front Cardiovasc Med       Date:  2018-02-05
View more
  3 in total

1.  Acetylcholine-synthesizing macrophages in subcutaneous fat are regulated by β2 -adrenergic signaling.

Authors:  Alexander J Knights; Shanshan Liu; Yingxu Ma; Victoria S Nudell; Eric Perkey; Matthew J Sorensen; Robert T Kennedy; Ivan Maillard; Li Ye; Heejin Jun; Jun Wu
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 11.598

2.  Robust temporal map of human in vitro myelopoiesis using single-cell genomics.

Authors:  Clara Alsinet; Maria Nascimento Primo; Valentina Lorenzi; Erica Bello; Iva Kelava; Carla P Jones; Roser Vilarrasa-Blasi; Carmen Sancho-Serra; Andrew J Knights; Jong-Eun Park; Beata S Wyspianska; Gosia Trynka; David F Tough; Andrew Bassett; Daniel J Gaffney; Damiana Alvarez-Errico; Roser Vento-Tormo
Journal:  Nat Commun       Date:  2022-05-24       Impact factor: 17.694

3.  Comprehensive Analysis of ceRNA Regulation Network Involved in the Development of Coronary Artery Disease.

Authors:  Jiabei He; Xinglong Li; Yao Zhang; Qingqing Zhang; Lianhong Li
Journal:  Biomed Res Int       Date:  2021-01-14       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.